
INSIGHTS & ANALYSES
“Shall We Dance?”— Biologic-Biosimilar Competition Under the Biologics Price Competition and Innovation Act
As more biosimilar applications are filed, courts will inevitably face the novel and complex issues posed by the BPCIA with increasing frequency. I. ...